(Total Views: 837)
Posted On: 02/17/2023 10:04:45 AM
Post# of 154883
There is a new study posted on Clinical Trials, but I don't understand it. Here is the description:
Brief Summary:
This is a Phase II Study of Leronlimab (PRO 140) in combination with Regorafenib in Patients with CCR5+, Microsatellite Stable (MSS), Metastatic Colorectal Cancer (mCRC)
It shows the following status:
Recruitment Status : Withdrawn (No participants enrolled)
It also shows Amarex as a collaborator.
V1 was submitted 2/7/23 and V2 was submitted 2/15/23. You can see the 2 versions side-by-side at link below.
Could this just be a record-keeping entry about a trial that has been dropped? If anyone understands what this is about, please post.
Thanks
https://clinicaltrials.gov/ct2/history/NCT057...udyPageTop
Brief Summary:
This is a Phase II Study of Leronlimab (PRO 140) in combination with Regorafenib in Patients with CCR5+, Microsatellite Stable (MSS), Metastatic Colorectal Cancer (mCRC)
It shows the following status:
Recruitment Status : Withdrawn (No participants enrolled)
It also shows Amarex as a collaborator.
V1 was submitted 2/7/23 and V2 was submitted 2/15/23. You can see the 2 versions side-by-side at link below.
Could this just be a record-keeping entry about a trial that has been dropped? If anyone understands what this is about, please post.
Thanks
https://clinicaltrials.gov/ct2/history/NCT057...udyPageTop
(1)
(0)
